Antimicrobial Susceptibility Testing Market Estimated to Reach US$3,525.75 Mn by 2022, with a CAGR of 6.4%
 |
| Antimicrobial Susceptibility Testing Market |
Market
Overview:
The global Antimicrobial Susceptibility Testing market is expected to reach a
value of US$3,525.75 Million In 2022,
with a compound annual growth rate (CAGR)
of 6.4% during the forecast period of 2022-2030. Antimicrobial
susceptibility testing is a vital tool in determining the appropriate
antimicrobial therapy for patients with infectious diseases. It helps in
identifying the susceptibility patterns of microorganisms and aids in the
selection of antibiotics for effective treatment. The need for accurate and
reliable susceptibility tests to combat the growing problem of antimicrobial
resistance is driving market growth. Additionally, the rising prevalence of
infectious diseases and the increasing demand for rapid diagnostic methods are
further fueling market expansion.
Market Key Trends:
One key trend in the Antimicrobial Susceptibility Testing market is the growing
adoption of automated systems. With the increasing demand for rapid and
accurate results, automated systems have become crucial in antimicrobial
susceptibility testing. These systems provide standardized and reproducible
results, reducing the chances of errors and ensuring precise diagnosis. They
also offer faster turnaround times and increased efficiency, making them highly
valuable in clinical settings. Moreover, automated systems help in overcoming
the limitations of manual testing methods, such as subjective interpretation
and labor-intensive processes. As a result, the demand for automated systems is
expected to rise significantly in the coming years, driving market growth.
Segment Analysis:
The Antimicrobial Susceptibility Testing market can be segmented based on
product type, application, end-user, and region.
In terms of product type, the dominating segment in the Antimicrobial
Susceptibility Testing Market is
the automated testing systems. This segment is expected to witness high growth
due to the increasing adoption of automated systems in clinical laboratories
and hospitals for accurate and reliable antimicrobial susceptibility testing.
Automated testing systems offer faster results, higher throughput, and reduced
human errors, which makes them highly preferable in healthcare settings.
Key Takeaways:
The global Antimicrobial Susceptibility Testing market is expected to witness
high growth, exhibiting a CAGR of 6.4%
over the forecast period (2022-2030). This growth can be attributed to the
increasing prevalence of infectious diseases, the growing need for effective
antimicrobial treatments, and the rising adoption of automated testing systems
in clinical laboratories.
Regionally, North America is expected to be the fastest-growing and dominating
region in the Antimicrobial Susceptibility Testing market. This can be
attributed to the presence of well-established healthcare infrastructure,
increasing investments in research and development activities, and the high
prevalence of infectious diseases in the region. Additionally, the Asia Pacific
region is also expected to witness significant growth in the market, driven by
the increasing healthcare expenditure, growing awareness about antimicrobial resistance,
and the rising demand for advanced testing methods.
Key players operating in the Antimicrobial Susceptibility Testing market
include Thermo Fisher Scientific Inc., BIOMÉRIEUX, HiMedia Laboratories, Alifax
S.r.l. Italy, Creative Diagnostics, Resistell AG, Danaher, Becton, Dickinson
and Company, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui
Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd., Synbiosis, Mast Group
Ltd., ELITechGroup, Flinn Scientific, CONDALAB, Accelerate Diagnostics, Inc.,
and Zhuhai DL Biotech Co., Ltd. These key players are focusing on product
launches, partnerships, and collaborations to strengthen their market presence
and expand their product portfolio.
Comments
Post a Comment